US 9061016
Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
granted A61KA61K31/439A61K31/444
Quick answer
US patent 9061016 (Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease) held by APREA AB expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- APREA AB
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/439, A61K31/444, A61K31/496, A61K31/519